Added to YB: 2017-07-30
Pitch date: 2017-07-30
RVNC:US [bullish]
Revance Therapeutics, Inc.
-89.82%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally.
Market Cap
$383.0M
Pitch Price
$35.85
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.92
P/E
-1.17
EV/Sales
2.66
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Revance Therapeutics, Inc. RVNC:US
A summary for this pitch has not been created yet.
Read full article (0 min)